Skip to main content

Fatigue

  • Chapter

Abstract

Fatigue, the number one symptom reported by cancer patients, is associated with the underlying disease, anticancer treatments, and other co-morbid factors. This chapter reviews the state of the problem, ongoing research, and interventions that the healthcare provider can consider in the diagnosis, evaluation and treatment of individuals experiencing cancer related fatigue.

Keywords

  • Cancer Survivor
  • Breast Cancer Survivor
  • National Comprehensive Cancer Network
  • National Comprehensive Cancer Network
  • Cancer Cachexia

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, access via your institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • DOI: 10.1007/978-3-319-24814-1_10
  • Chapter length: 19 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   89.00
Price excludes VAT (USA)
  • ISBN: 978-3-319-24814-1
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Softcover Book
USD   119.99
Price excludes VAT (USA)
Fig. 10.1

References

  1. Mortimer JE, Barsevick AM, Bennett CL, Berger AM, Cleeland C, DeVader SR, et al. Studying cancer-related fatigue: report of the NCCN scientific research committee. J Natl Compr Cancer Netw. 2010;8(12):1331–9.

    Google Scholar 

  2. NCI Fact Sheets [Internet]. Available from: http://www.cancer.gov/cancertopics/factsheet.

  3. Berger AM, Gerber LH, Mayer DK. Cancer-related fatigue: implications for breast cancer survivors. Cancer. 2012;118(8 Suppl):2261–9.

    PubMed  CrossRef  Google Scholar 

  4. Bower JE. Cancer-related fatigue—mechanisms, risk factors, and treatments. Nat Rev Clin Oncol. 2014;11(10):597–609.

    CAS  PubMed  PubMed Central  CrossRef  Google Scholar 

  5. Cancer.Net [Internet]. Cancer.Net. [Cited 26 Dec 2014]. Available from: http://www.cancer.net/.

  6. Fiorentino L, Rissling M, Liu L, Ancoli-Israel S. The symptom cluster of sleep, fatigue and depressive symptoms in breast cancer patients: severity of the problem and treatment options. Drug Discov Today Dis Models. 2011;8(4):167–73.

    PubMed  PubMed Central  CrossRef  Google Scholar 

  7. Minton O, Berger A, Barsevick A, Cramp F, Goedendorp M, Mitchell SA, et al. Cancer-related fatigue and its impact on functioning. Cancer. 2013;119 Suppl 11:2124–30.

    PubMed  CrossRef  Google Scholar 

  8. Wang XS, Zhao F, Fisch MJ, O’Mara AM, Cella D, Mendoza TR, et al. Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors. Cancer. 2014;120(3):425–32.

    PubMed  PubMed Central  CrossRef  Google Scholar 

  9. Fatigue (PDQ®) [Internet]. National Cancer Institute. [Cited 29 Sep 2014]. Available from: http://www.cancer.gov/cancertopics/pdq/supportivecare/fatigue/Patient/page2.

  10. Ancoli-Israel S, Liu L, Marler MR, Parker BA, Jones V, Sadler GR, et al. Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer. Support Care Cancer. 2006;14(3):201–9.

    PubMed  CrossRef  Google Scholar 

  11. Jacobsen PB, Hann DM, Azzarello LM, Horton J, Balducci L, Lyman GH. Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates. J Pain Symptom Manage. 1999;18(4):233–42.

    CAS  PubMed  CrossRef  Google Scholar 

  12. Donovan KA, Jacobsen PB, Andrykowski MA, Winters EM, Balducci L, Malik U, et al. Course of fatigue in women receiving chemotherapy and/or radiotherapy for early stage breast cancer. J Pain Symptom Manage. 2004;28(4):373–80.

    PubMed  PubMed Central  CrossRef  Google Scholar 

  13. Bower JE, Ganz PA, Desmond KA, Bernaards C, Rowland JH, Meyerowitz BE, et al. Fatigue in long-term breast carcinoma survivors. Cancer. 2006;106(4):751–8.

    PubMed  CrossRef  Google Scholar 

  14. Benoy I, Salgado R, Colpaert C, Weytjens R, Vermeulen PB, Dirix LY. Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients. Clin Breast Cancer. 2002;2(4):311–5.

    CAS  PubMed  CrossRef  Google Scholar 

  15. Bower JE, Lamkin DM. Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications. Brain Behav Immun. 2013;30(Suppl):S48–57.

    CAS  PubMed  CrossRef  Google Scholar 

  16. Felger JC, Miller AH. Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise. Front Neuroendocrinol. 2012;33(3):315–27.

    CAS  PubMed  PubMed Central  CrossRef  Google Scholar 

  17. Aggarwal BB, Vijayalekshmi RV, Sung B. Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. Clin Cancer Res. 2009;15(2):425–30.

    CAS  PubMed  CrossRef  Google Scholar 

  18. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860–7.

    CAS  PubMed  PubMed Central  CrossRef  Google Scholar 

  19. Stone HB, Coleman CN, Anscher MS, McBride WH. Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol. 2003;4(9):529–36.

    CAS  PubMed  CrossRef  Google Scholar 

  20. Meyers CA, Albitar M, Estey E. Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer. 2005;104(4):788–93.

    CAS  PubMed  CrossRef  Google Scholar 

  21. Lutgendorf SK, Weinrib AZ, Penedo F, Russell D, DeGeest K, Costanzo ES, et al. Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients. J Clin Oncol. 2008;26(29):4820–7.

    CAS  PubMed  PubMed Central  CrossRef  Google Scholar 

  22. Clevenger L, Schrepf A, Christensen D, DeGeest K, Bender D, Ahmed A, et al. Sleep disturbance, cytokines, and fatigue in women with ovarian cancer. Brain Behav Immun. 2012;26(7):1037–44.

    PubMed  PubMed Central  CrossRef  Google Scholar 

  23. Arpin D, Perol D, Blay J-Y, Falchero L, Claude L, Vuillermoz-Blas S, et al. Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis. J Clin Oncol. 2005;23(34):8748–56.

    CAS  PubMed  CrossRef  Google Scholar 

  24. Mills PJ, Parker B, Jones V, Adler KA, Perez CJ, Johnson S, et al. The effects of standard anthracycline-based chemotherapy on soluble ICAM-1 and vascular endothelial growth factor levels in breast cancer. Clin Cancer Res. 2004;10(15):4998–5003.

    CAS  PubMed  CrossRef  Google Scholar 

  25. Pertl MM, Hevey D, Boyle NT, Hughes MM, Collier S, O’Dwyer A-M, et al. C-reactive protein predicts fatigue independently of depression in breast cancer patients prior to chemotherapy. Brain Behav Immun. 2013;34:108–19.

    CAS  PubMed  CrossRef  Google Scholar 

  26. Bower JE, Ganz PA, Tao ML, Hu W, Belin TR, Sepah S, et al. Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer. Clin Cancer Res. 2009;15(17):5534–40.

    CAS  PubMed  PubMed Central  CrossRef  Google Scholar 

  27. Lamkin DM, Lutgendorf SK, Lubaroff D, Sood AK, Beltz TG, Johnson AK. Cancer induces inflammation and depressive-like behavior in the mouse: modulation by social housing. Brain Behav Immun. 2011;25(3):555–64.

    CAS  PubMed  CrossRef  Google Scholar 

  28. Van der Meeren A, Lebaron-Jacobs L. Behavioural consequences of an 8 Gy total body irradiation in mice: regulation by interleukin-4. Can J Physiol Pharmacol. 2001;79(2):140–3.

    PubMed  CrossRef  Google Scholar 

  29. Brush J, Lipnick SL, Phillips T, Sitko J, McDonald JT, McBride WH. Molecular mechanisms of late normal tissue injury. Semin Radiat Oncol. 2007;17(2):121–30.

    PubMed  CrossRef  Google Scholar 

  30. Fagundes CP, Glaser R, Alfano CM, Bennett JM, Povoski SP, Lipari AM, et al. Fatigue and herpesvirus latency in women newly diagnosed with breast cancer. Brain Behav Immun. 2012;26(3):394–400.

    PubMed  CrossRef  Google Scholar 

  31. Cramp F, Byron-Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev. 2012;11:CD006145.

    Google Scholar 

  32. Fong DYT, Ho JWC, Hui BPH, Lee AM, Macfarlane DJ, Leung SSK, et al. Physical activity for cancer survivors: meta-analysis of randomised controlled trials. BMJ. 2012;344:e70.

    PubMed  PubMed Central  CrossRef  Google Scholar 

  33. Van Weert E, May AM, Korstjens I, Post WJ, van der Schans CP, van den Borne B, et al. Cancer-related fatigue and rehabilitation: a randomized controlled multicenter trial comparing physical training combined with cognitive-behavioral therapy with physical training only and with no intervention. Phys Ther. 2010;90(10):1413–25.

    PubMed  CrossRef  Google Scholar 

  34. Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvão DA, Pinto BM, et al. American college of sports medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc. 2010;42(7):1409–26.

    PubMed  CrossRef  Google Scholar 

  35. Repka CP, Peterson BM, Brown JM, Lalonde TL, Schneider CM, Hayward R. Cancer type does not affect exercise-mediated improvements in cardiorespiratory function and fatigue. Integr Cancer Ther. 2014;13(6):473–81.

    Google Scholar 

  36. Mishra SI, Scherer RW, Snyder C, Geigle P, Gotay C. Are exercise programs effective for improving health-related quality of life among cancer survivors? A systematic review and meta-analysis. Oncol Nurs Forum. 2014;41(6):E326–42.

    PubMed  PubMed Central  CrossRef  Google Scholar 

  37. Kiecolt-Glaser JK, Bennett JM, Andridge R, Peng J, Shapiro CL, Malarkey WB, et al. Yoga’s impact on inflammation, mood, and fatigue in breast cancer survivors: a randomized controlled trial. J Clin Oncol. 2014;32(10):1040–9.

    PubMed  PubMed Central  CrossRef  Google Scholar 

  38. Larkey LK, Roe DJ, Weihs KL, Jahnke R, Lopez AM, Rogers CE, et al. Randomized controlled trial of qigong/Tai Chi easy on cancer-related fatigue in breast cancer survivors. Ann Behav Med. 2014;49(2):165–76.

    CrossRef  Google Scholar 

  39. Ling W-M, Lui LYY, So WKW, Chan K. Effects of acupuncture and acupressure on cancer-related fatigue: a systematic review. Oncol Nurs Forum. 2014;41(6):581–92.

    PubMed  CrossRef  Google Scholar 

  40. Bower JE, Ganz PA, Aziz N. Altered cortisol response to psychologic stress in breast cancer survivors with persistent fatigue. Psychosom Med. 2005;67(2):277–80.

    PubMed  CrossRef  Google Scholar 

  41. Bower JE, Ganz PA, Dickerson SS, Petersen L, Aziz N, Fahey JL. Diurnal cortisol rhythm and fatigue in breast cancer survivors. Psychoneuroendocrinology. 2005;30(1):92–100.

    CAS  PubMed  CrossRef  Google Scholar 

  42. Yun YH, Lee KS, Kim Y-W, Park SY, Lee ES, Noh D-Y, et al. Web-based tailored education program for disease-free cancer survivors with cancer-related fatigue: a randomized controlled trial. J Clin Oncol. 2012;30(12):1296–303.

    PubMed  CrossRef  Google Scholar 

  43. Johnson RL, Block I, Gold MA, Markwell S, Zupancic M. Effect of methylphenidate on fatigue in women with recurrent gynecologic cancer. Psychooncology. 2010;19(9):955–8.

    PubMed  CrossRef  Google Scholar 

  44. Escalante CP, Meyers C, Reuben JM, Wang X, Qiao W, Manzullo E, et al. A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patients. Cancer J. 2014;20(1):8–14.

    CAS  PubMed  PubMed Central  CrossRef  Google Scholar 

  45. Bruera E, Yennurajalingam S, Palmer JL, Perez-Cruz PE, Frisbee-Hume S, Allo JA, et al. Methylphenidate and/or a nursing telephone intervention for fatigue in patients with advanced cancer: a randomized, placebo-controlled, phase II trial. J Clin Oncol. 2013;31(19):2421–7.

    CAS  PubMed  PubMed Central  CrossRef  Google Scholar 

  46. Moraska AR, Sood A, Dakhil SR, Sloan JA, Barton D, Atherton PJ, et al. Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial. J Clin Oncol. 2010;28(23):3673–9.

    CAS  PubMed  PubMed Central  CrossRef  Google Scholar 

  47. Ruddy KJ, Barton D, Loprinzi CL. Laying to rest psychostimulants for cancer-related fatigue? J Clin Oncol. 2014;32(18):1865–7.

    CAS  PubMed  CrossRef  Google Scholar 

  48. Yennurajalingam S, Bruera E. Role of corticosteroids for fatigue in advanced incurable cancer: is it a “wonder drug” or “deal with the devil.”. Curr Opin Support Palliat Care. 2014;8(4):346–51.

    PubMed  CrossRef  Google Scholar 

  49. Paulsen O, Klepstad P, Rosland JH, Aass N, Albert E, Fayers P, et al. Efficacy of methylprednisolone on pain, fatigue, and appetite loss in patients with advanced cancer using opioids: a randomized, placebo-controlled, double-blind trial. J Clin Oncol. 2014;32(29):3221–8.

    CAS  PubMed  CrossRef  Google Scholar 

  50. Yennurajalingam S, Frisbee-Hume S, Palmer JL, Delgado-Guay MO, Bull J, Phan AT, et al. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. J Clin Oncol. 2013;31(25):3076–82.

    CAS  PubMed  CrossRef  Google Scholar 

  51. Dantzer R, Heijnen CJ, Kavelaars A, Laye S, Capuron L. The neuroimmune basis of fatigue. Trends Neurosci. 2014;37(1):39–46.

    CAS  PubMed  CrossRef  Google Scholar 

  52. Barton DL, Liu H, Dakhil SR, Linquist B, Sloan JA, Nichols CR, et al. Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2. J Natl Cancer Inst. 2013;105(16):1230–8.

    PubMed  PubMed Central  CrossRef  Google Scholar 

  53. Cruciani RA, Zhang JJ, Manola J, Cella D, Ansari B, Fisch MJ. L-carnitine supplementation for the management of fatigue in patients with cancer: an eastern cooperative oncology group phase III, randomized, double-blind, placebo-controlled trial. J Clin Oncol. 2012;30(31):3864–9.

    CAS  PubMed  PubMed Central  CrossRef  Google Scholar 

  54. Minton O, Richardson A, Sharpe M, Hotopf M, Stone P. A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue. J Natl Cancer Inst. 2008;100(16):1155–66.

    CAS  PubMed  CrossRef  Google Scholar 

  55. Fact Sheets [Internet]. National Cancer Institute. [Cited 26 Dec 2014]. Available from: http://www.cancer.gov/cancertopics/factsheet.

  56. Garland SN, Johnson JA, Savard J, Gehrman P, Perlis M, Carlson L, et al. Sleeping well with cancer: a systematic review of cognitive behavioral therapy for insomnia in cancer patients. Neuropsychiatr Dis Treat. 2014;10:1113–24.

    PubMed  PubMed Central  Google Scholar 

  57. Muscaritoli M, Bossola M, Aversa Z, Bellantone R, Rossi FF. Prevention and treatment of cancer cachexia: new insights into an old problem. Eur J Cancer. 2006;42(1):31–41.

    CAS  PubMed  CrossRef  Google Scholar 

  58. Jameson GS, Hoff DDV, Weiss GJ, Richards DA, Smith DA, Becerra C, et al. Safety of the antimyostatin monoclonal antibody LY2495655 in healthy subjects and patients with advanced cancer. J Clin Oncol [Internet]. 2012 [Cited 7 Jan 2015];30(suppl; abstr 2516). Available from: http://meetinglibrary.asco.org/content/98731-114.

  59. Maughan D, Toth M. Discerning primary and secondary factors responsible for clinical fatigue in multisystem diseases. Biology Basel. 2014;3(3):606–22.

    PubMed  PubMed Central  Google Scholar 

  60. Practice & Research [Internet]. [Cited 7 Jan 2015]. Available from: http://www.asco.org/practice-research.

  61. Practice Guidelines [Internet]. [Cited 7 Jan 2015]. Available from: http://www.instituteforquality.org/practice-guidelines.

  62. Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL, et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. 2012;62(4):243–74.

    PubMed  CrossRef  Google Scholar 

  63. Courneya KS, Friedenreich CM, Franco-Villalobos C, Crawford JJ, Chua N, Basi S, et al. Effects of supervised exercise on progression-free survival in lymphoma patients: an exploratory follow-up of the HELP Trial. Cancer Causes Control. 2014;26:269–76.

    PubMed  CrossRef  Google Scholar 

  64. Garcia SF, Cella D, Clauser SB, Flynn KE, Lad T, Lai J-S, et al. Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative. J Clin Oncol. 2007;25(32):5106–12.

    PubMed  CrossRef  Google Scholar 

  65. Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, et al. The rapid assessment of fatigue severity in cancer patients: use of the brief fatigue inventory. Cancer. 1999;85(5):1186–96.

    CAS  PubMed  CrossRef  Google Scholar 

  66. Cella D. Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) scales. Version 4. Evanston: Evanston Northwestern Healthcare; 1997.

    Google Scholar 

  67. Piper BF, Dibble SL, Dodd MJ, Weiss MC, Slaughter RE, Paul SM. The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum. 1998;25(4):677–84.

    CAS  PubMed  Google Scholar 

  68. Reeve BB, Stover AM, Alfano CM, Smith AW, Ballard-Barbash R, Bernstein L, et al. The Piper Fatigue Scale-12 (PFS-12): psychometric findings and item reduction in a cohort of breast cancer survivors. Breast Cancer Res Treat. 2012;136(1):9–20.

    PubMed  PubMed Central  CrossRef  Google Scholar 

  69. Schwartz AL. The Schwartz Cancer Fatigue Scale: testing reliability and validity. Oncol Nurs Forum. 1998;25(4):711–7.

    CAS  PubMed  Google Scholar 

  70. Hann DM, Denniston MM, Baker F. Measurement of fatigue in cancer patients: further validation of the Fatigue Symptom Inventory. Qual Life Res. 2000;9(7):847–54.

    CAS  PubMed  CrossRef  Google Scholar 

  71. Lee KA, Hicks G, Nino-Murcia G. Validity and reliability of a scale to assess fatigue. Psychiatry Res. 1991;36(3):291–8.

    CAS  PubMed  CrossRef  Google Scholar 

  72. Okuyama T, Akechi T, Kugaya A, Okamura H, Shima Y, Maruguchi M, et al. Development and validation of the cancer fatigue scale: a brief, three-dimensional, self-rating scale for assessment of fatigue in cancer patients. J Pain Symptom Manage. 2000;19(1):5–14.

    CAS  PubMed  CrossRef  Google Scholar 

  73. Stein KD, Jacobsen PB, Blanchard CM, Thors C. Further validation of the multidimensional fatigue symptom inventory-short form. J Pain Symptom Manage. 2004;27(1):14–23.

    PubMed  PubMed Central  CrossRef  Google Scholar 

  74. Hospice & Palliative Nurses Association [Internet]. Available from: http://hpna.advancingexpertcare.org/.

Download references

Acknowledgment

The author is grateful to James Mancuso for his expert assistance in the preparation of this chapter.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gayle Jameson MSN, ACNP-BC, AOCN .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and Permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Jameson, G., Von Hoff, D. (2016). Fatigue. In: Alberts, D., Lluria-Prevatt, M., Kha, S., Weihs, K. (eds) Supportive Cancer Care. Springer, Cham. https://doi.org/10.1007/978-3-319-24814-1_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-24814-1_10

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-24812-7

  • Online ISBN: 978-3-319-24814-1

  • eBook Packages: MedicineMedicine (R0)